文献速递细菌感染、耐药与抗菌药物

2004-14年欧洲健康牛羊猪鸡肠道球菌耐药监测(EASSA研究)

Antimicrobial resistance monitoring in commensal enterococci from healthy cattle, pigs and chickens across Europe during 2004-14 (EASSA Study).
PubMed 文献 · J Antimicrob Chemother · 2019-01-01

EASSA项目在屠宰场随机采集欧洲健康牛、猪、鸡的肠道内容物,分离肠球菌并用CLSI琼脂稀释法集中测定药物敏感性。共获得2435株屎肠球菌和1389株粪肠球菌,对临床重要抗生素的耐药率总体低或为零,但对四环素和红霉素耐药率很高,且耐药性因药物、动物种类、国家和菌种而异。

要点

  • 临床对利奈唑胺、达托霉素、万古霉素、替加环素、氨苄西林和庆大霉素的耐药罕见或为零。
  • 屎肠球菌对奎奴普丁/达福普丁的临床耐药率为2.2%-33.6%。
  • 猪和鸡源肠球菌对四环素(67.4%-79.1%)和红霉素(27.1%-57.0%)耐药率很高。

核心结论

  • 欧洲健康食用动物源共生肠球菌对关键临床抗生素的耐药率总体低或为零,但对四环素和红霉素耐药率很高。

研究设计与样本

  • EASSA项目在屠宰场随机采集健康牛、猪、鸡的肠道内容物,每个国家至少4个屠宰场,每场每动物每农场1份样本。
  • 共分离2435株屎肠球菌和1389株粪肠球菌,用CLSI琼脂稀释法集中测定药物敏感性。
  • 采用CLSI临床折点和EUCAST流行病学 cut-off 值(NWT)判读结果。

主要发现

  • 7株屎肠球菌/粪肠球菌对利奈唑胺耐药;1株屎肠球菌对达托霉素非野生型(MIC 8 mg/L)。
  • 临床万古霉素耐药极低或缺失,8株菌敏感性降低(MIC 8 mg/L);2株对替加环素临床耐药。
  • 屎肠球菌对奎奴普丁/达福普丁临床耐药率为2.2%-33.6%,NWT率为38.5%-83.2%。
  • 猪和鸡源屎肠球菌和粪肠球菌对四环素耐药率67.4%-79.1%,对红霉素耐药率27.1%-57.0%。
  • 海氏肠球菌(n=935)、耐久肠球菌(n=286)和铅黄肠球菌(n=154)对四环素和红霉素的NWT结果与屎肠球菌和粪肠球菌相似。

关键数值与推荐

  • 临床折点采用CLSI标准,流行病学 cut-off 值采用EUCAST标准。
  • 屎肠球菌对奎奴普丁/达福普丁临床耐药率2.2%-33.6%,NWT率38.5%-83.2%。
  • 猪和鸡源肠球菌对四环素耐药率67.4%-79.1%,对红霉素耐药率27.1%-57.0%。
  • 利奈唑胺耐药7株,达托霉素NWT 1株(MIC 8 mg/L),万古霉素敏感性降低8株(MIC 8 mg/L),替加环素临床耐药2株。

临床怎么用

  • 提示临床医生,健康食用动物源肠球菌对利奈唑胺、万古霉素、达托霉素和替加环素的耐药罕见。
  • 四环素和红霉素的高耐药率提示应关注动物源肠球菌作为耐药基因储库的潜在风险。
  • 监测结果可用于评估食用动物中肠球菌耐药性的时空变化,为抗菌药物管理提供参考。

局限性

  • 仅纳入健康食用动物源共生肠球菌,未涉及临床感染分离株。
  • 研究期间为2004-14年,结果可能不反映当前耐药状况。
  • 未报告具体国家间差异的数值和统计比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The European Antimicrobial Susceptibility Surveillance in Animals (EASSA) programme collects zoonotic and commensal bacteria from healthy food-producing animals at slaughter and tracks their susceptibility to medically important antibiotics. Results for enterococci, collected over three time periods, are presented. METHODS: Intestinal contents from cattle, pigs and chickens were randomly sampled (five or six countries/host; at least four abattoirs/country; one sample/animal/farm) for isolation of enterococci; antimicrobial susceptibilities were centrally assessed by CLSI agar dilution. Clinical breakpoints (CLSI) and epidemiological cut-off values (EUCAST) were applied for data interpretation. RESULTS: In total, 2435 Enterococcus faecium and 1389 Enterococcus faecalis strains were recovered. Seven E. faecium/faecalis strains were linezolid resistant. One E. faecium strain was non-WT (NWT), with a daptomycin MIC of 8 mg/L. Clinical vancomycin resistance was very low or absent; eight strains had decreased susceptibility (MICs of 8 mg/L). Two strains were clinically resistant to tigecycline. Little resistance to ampicillin or gentamicin was observed. Clinical resistance of E. faecium to quinupristin/dalfopristin was slightly higher (2.2%-33.6%) and 38.5%-83.2% of the strains were classified NWT. Very high resistance to tetracycline (67.4%-79.1%) and erythromycin (27.1%-57.0%) was noted for E. faecium and E. faecalis in pigs and chickens. For both of these compounds, similar NWT results were observed for Enterococcus hirae (n = 935), Enterococcus durans (n = 286) and Enterococcus casseliflavus (n = 154) whereas the percentage of NWT for linezolid, tigecycline and vancomycin was generally zero or low. CONCLUSIONS: In this pan-EU survey of commensal enterococci, antibiotic susceptibility varied widely between antibiotics, animal species, countries and enterococcal species. Clinical resistance to antibiotics that are critically important for human medicine was absent or low, except for erythromycin.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. de Jong A, Simjee S, Rose M, et al. Antimicrobial resistance monitoring in commensal enterococci from healthy cattle, pigs and chickens across Europe during 2004-14 (EASSA Study). J Antimicrob Chemother. 2019. PMID: 30624665. doi:10.1093/jac/dky537

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。